webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Methyl 1-Cbz-azetidine-3-carboxylate

  CAS No.: 757239-60-4   Cat No.: BADC-01931   Purity: 97.0% 4.5  

Methyl 1-Cbz-azetidine-3-carboxylate is a cyclic linker intermediate used in rigidifying ADC linkers or peptidomimetics, supporting improved payload control.

Methyl 1-Cbz-azetidine-3-carboxylate

Structure of 757239-60-4

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C13H15NO4
Molecular Weight
249.26

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Azetidine-1,3-dicarboxylic acid 1-benzyl ester 3-methyl ester; 1,3-Azetidinedicarboxylic acid, 3-methyl 1-(phenylmethyl) ester
IUPAC Name
1-O-benzyl 3-O-methyl azetidine-1,3-dicarboxylate
Canonical SMILES
COC(=O)C1CN(C1)C(=O)OCC2=CC=CC=C2
InChI
InChI=1S/C13H15NO4/c1-17-12(15)11-7-14(8-11)13(16)18-9-10-5-3-2-4-6-10/h2-6,11H,7-9H2,1H3
InChIKey
VMBHUIMZBSWWCN-UHFFFAOYSA-N
Density
1.3±0.1 g/cm3
Boiling Point
414.9±45.0 °C at 760 mmHg

Methyl 1-Cbz-azetidine-3-carboxylate is a valuable compound in organic synthesis and pharmaceutical research, with several key applications. Here are some of its primary applications:

Peptide Synthesis: Methyl 1-Cbz-azetidine-3-carboxylate is used as a building block in the synthesis of peptides, particularly those containing azetidine ring structures. Its stable carbamate protective group, Cbz, allows for selective deprotection under mild conditions, making it versatile in peptide chemistry. This aids researchers in developing novel peptides for therapeutic and research purposes.

Pharmaceutical Development: This compound serves as an intermediate in the synthesis of various pharmaceuticals, particularly those targeting special ring structures for improved drug efficacy. Its unique reactive properties facilitate the construction of complex molecular architectures in drug discovery. Researchers leverage this versatility to optimize drug candidates, enhancing bioavailability and stability.

Chiral Synthesis: Methyl 1-Cbz-azetidine-3-carboxylate is used in asymmetric synthesis to introduce chirality in pharmaceutical compounds and other active molecules. It acts as a key chiral auxiliary or precursor that enables the synthesis of enantiomerically pure products. This is crucial for the development of drugs where stereochemistry significantly impacts therapeutic outcomes.

Chemical Research: Researchers utilize this compound in studying reaction mechanisms and exploring new synthetic methodologies. Its structure allows chemists to investigate ring-opening reactions and other transformations that can lead to new chemical entities. By understanding its reactivity, scientists can advance the field of synthetic organic chemistry and develop novel synthetic approaches.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Boc-D-Dap(N3) CHA salt
Send Inquiry
Verification code
Inquiry Basket